Interesting Engineering on MSN1mon
FDA calls Neuralink’s Blindsight a ‘breakthrough’ as Musk eyes vision for blind
The FDA’s breakthrough designation for Blindsight signals that the technology holds considerable promise and could contribute ...
pharmaphorum1mon
Neuralink gets breakthrough tag for sight-restoring implant
Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.
From AI to Musk’s brain chips, the FDA’s device unit faces rapid change
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
pharmaphorum1d
First human subject receives a Neuralink brain implant
Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.
The Daily Star27d
neuralink brain chip
Blindsight, the experimental vision-restoring implant by Elon Musk’s brain-chip startup, Neuralink, has received the U.S. Food and Drug Administration’s (FDA) "breakthrough device" designation ...
Reuters7d
Neuralink Corp.
Disruptedcategory Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant September 18, 2024 Healthcare & Pharmaceuticalscategory Musk's Neuralink says second trial implant ...
The Hill21d
FDA recalls thousands of antidepressant bottles due to cancer-causing chemical
The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to the possible presence of a carcinogen. Duloxetine belongs to a ...
USA Today22d
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical
Per the FDA, nitrosamine impurities "may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time." However, it added, "a person taking a ...
Yahoo22d
FDA issues recall for antidepressant drug
Over 7,000 bottles of Duloxetine were recalled due to the elevated presence of Nitrosamine, an ingredient believed to be cancerous, according to the FDA. The agency labeled the recall as a Class ...
STAT12d
Novo asks FDA to bar compounders from making Ozempic copies
Compounding pharmacies are typically allowed to make copies of drugs that are deemed to be in shortage by the FDA, which semaglutide has been for over two years. But Novo argued that semaglutide ...
USA Today27d
Injectable drug to ease advanced Parkinson's disease symptoms approved by FDA
The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...
U.S. News & World Report1mon
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now By Robin Foster HealthDay Reporter TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making ...